TENS on Pain Intensity in Primary Dysmenorrhea
TENSinPain
Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Amelioration of Pain Associated With Primary Dysmenorrhea in Female Undergraduates of a Nigerian University
1 other identifier
interventional
25
1 country
1
Brief Summary
Dysmenorrhoea is a common problem in women of reproductive age. It is associated with painful uterine contractions and discomfort. The primary aim of the study was to determine the effect of Transcutaneous Electrical Nerve Stimulation (TENS) on pain intensity associated with primary dysmenorrhoea among female undergraduate students of Obafemi Awolowo University. The study involved 50 females undergraduates of Obafemi Awolowo University with primary dysmenorrhoea lasting for at least 5 days. They were allocated in to two groups equally. One group was treated with TENS and other group served as control. The treatment was for 5 days and Pain intensity was measured before and after the treatment in the two groups. The post treatment pain intensity was then compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2018
CompletedFirst Submitted
Initial submission to the registry
February 19, 2018
CompletedFirst Posted
Study publicly available on registry
February 27, 2018
CompletedFebruary 27, 2018
February 1, 2018
3 months
February 19, 2018
February 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analogue scale
The scale is from 0-5. 0 is no pain 3 is severe pain and 5 is excruciating pain
5 days
Study Arms (2)
TENS
EXPERIMENTALIt consists of 25 subjects with primary dysmenorrhea which were put on TENS for 30 minutes, three for 3 days. The subject were placed in supine lying in a comfortable position as possible. The abdomen to the inguinal region were decently exposed and cleaned, after inspection of the area for cuts, skin infections or any abnormalities. A pair of electrodes ( inactive electrodes) will be placed a little below the umbilicus ( Right and Left) and the other pair(active electrode) along the inguinal region at the level of pubic symphysis ( Right and Left) according to (Akinbo et al 2000). A quadripolar method will be used for electrode placement.
Control
NO INTERVENTIONThese are 25 subjects which were not in any intervention. These were subjects that were not placed on TENS and were not used to drug taken for the amelioration of the dysmenorrhea. They were educated on the purpose of research and their inform consent was obtained. Their pain intensity was measured firs, third and 5th days
Interventions
First, there was explanation of the overall test procedure. The subject was placed in supine lying in a comfortable position.A pair of electrodes (inactive electrodes) was placed a little below the umbilicus (Right and Left) and the other pair (active electrode) along the inguinal region at the level of pubic symphysis (Right and Left) according to (Akinbo et al 2000). The TENS equipment was switched on and the intensity was set at a level tolerable by each participant's. The treatment period lasted for 30 minutes for each treatment sessions and the procedure was carried out once a day on the 1st, 3rd and 5th days (Akinbo et.al 2000). Pain intensity was measured pre treatment and post treatment each day of treatment using the visual analogue scale (VAS).
Eligibility Criteria
You may qualify if:
- Participants with primary dysmenorrhoea, who is single, between the ages of 16 to 30 and have no history of conception, the primary dysmenorrhoea should be at least for five days.
You may not qualify if:
- Individuals presenting with pelvic diseases.
- Individuals with cardiac problem.
- Undergraduate with primary dysmenorrhoea but with history of conception.
- Undergraduate with primary dysmenorrhoea currently using analgesia for pain relief.
- Undergraduate with primary dysmenorrhoea not up to five days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Obafemi Awolowo University
Ile-Ife, Osun State, 220005, Nigeria
Related Publications (2)
Akin M, Price W, Rodriguez G Jr, Erasala G, Hurley G, Smith RP. Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhea. J Reprod Med. 2004 Sep;49(9):739-45.
PMID: 15493566BACKGROUNDAdams JM, Taylor AE, Schoenfeld DA, Crowley WF Jr, Hall JE. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab. 1994 Sep;79(3):858-64. doi: 10.1210/jcem.79.3.7521353.
PMID: 7521353RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adesola O Ojoawo, PhD
Obafemi Awolowo University, Ile Ife. Nigeria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr (Senior Lecturer
Study Record Dates
First Submitted
February 19, 2018
First Posted
February 27, 2018
Study Start
August 4, 2017
Primary Completion
November 10, 2017
Study Completion
February 16, 2018
Last Updated
February 27, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share
No plan